Chair of the Technical Advisory Group. Medical anthropologist at the London School of Hygiene & Tropical Medicine. Co-founder of the interdisciplinary Antimicrobial Resistance Centre. Research on lived experiences of AMR and antimicrobial use among patients, carers, health care workers, farmers and wider stakeholders.
Technical Advisory Group
The technical advisory group plays a key role in shaping the Fleming Fund and provides technical advice to support specific strategic and programmatic decisions. It is made up of 15 experts in the field of antimicrobial resistance (AMR) from a One Health context.
Dr Evelyn Wesangula
Deputy Chair Technical Advisory Group. Evelyn currently works with the East Central and Southern Africa Health Community (ECSA- HC) based in Arusha, Tanzania, as a senior AMR Control Specialist, strengthening the implementation National Action Plans on Antimicrobial Resistance in the region. She previously worked at the MOH in Kenya as the National AMR focal point.
Dr Didem Torumkuney
Scientific Director for Infectious Diseases Research at GlaxoSmithKline (GSK). Completed her PhD at the Medical Faculty in Istanbul in collaboration with the UK Health Security Agency (Public Health England-Colindale) on effect of environmental factors on AMR. She has 17 years antibiotic surveillance experience in different countries/regions. Didem’s research focuses on: AMR, global antibiotic surveillance studies, and antibiotic development. Currently, she works as clinical microbiology lead for tebipenem development at GSK.
Professor Franco Sassi
Professor of International Health Policy and Economics and Director of the Centre for Health Economics and Policy Innovation at Imperial College London. Franco's research focuses on economic analysis of health services, the economics of chronic disease prevention and measuring inequalities in access to healthcare. Franco is the Keynote Speaker at this year’s event.
Chair Clinical Infectious Diseases at the Faculty of Veterinary Medicine, Utrecht University. Jaap is also co-chair of the Quadripartite Technical Group on Integrated Surveillance for Antimicrobial Resistance and Use (QTG-AIS), director of the WHO Collaborating Centre for Campylobacter and Antimicrobial Resistance from a One Health Perspective, and of the WOAH Reference Centre for Campylobacteriosis.
Infectious disease epidemiologist, an Alborada Professor of Equine and Farm Animal Medicine and Head of University of Cambridge Vet School. Co-chairs the University of Cambridge Infectious Diseases Interdisciplinary Research Centre and conducts multidisciplinary research on infectious diseases.
Professor of Medicine, Pathology, and Global Health and Co-Director of the Centre for International Health, at the University of Otago, Dunedin. Also, Adjunct Professor of Medicine, Pathology and Global Health at Duke University and a Guest Researcher with the US centres for Disease Control and Prevention.
Dr Raheelah Ahmad
Reader, Health Systems at City St George's University of London. Global expertise in capacity strengthening for and evaluation of innovation and systems change.
Professor Aaron Oladipo Aboderin
Professor of Clinical Microbiology, Deputy Provost College of Medical Sciences and consultant clinical microbiologist at the Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria. His Primary focus of his research is on epidemiology of enteric infections, healthcare-associated infections, AMR, and antimicrobial stewardship.
Dr Abhilasha Karkey
Medical microbiologist involved in clinical research at Oxford University Clinical Research Unit Nepal, Patan Hospital. Abhilasha’s research focuses on enteric fever and antimicrobial resistance. She is both an OAK Scientific Leadership Fellow and an Alan J. Magill Fellow. Her current work focuses on hospital acquired infections and development of AMR in the community particularly among Gram-negative pathogens, especially Klebsiella pneumoniae and Enterobacter spp.
Professor William Gaze
leads a large research group within the University of Exeter Medical School’s Centre for Environment and Human Health focusing on AMR evolution, ecology and epidemiology in human, animal and environmental microbiomes. He has advised the UK government, EU and UNEP on the environmental dimension of AMR.
Dr Rajesh Bhatia
Medical microbiologist and former Director Communicable Diseases WHO Region for South-East Asia and Regional AMR Focal Point. Been consultant to FAO, UNEP, USAID and governments of Jordan, Egypt, Palestine in strengthening their AMR containment programmes. Currently also a member of Quadripartite Technical Group on AMR/AMU Integrated Surveillance.
Dr Freddy Kitutu
Senior Lecturer of Health Systems Pharmacy and former Dean in Makerere University, Uganda. Research interests include evaluation of complex pharmaceutical interventions to improve access to life-saving technologies and the nexus of formal, private health providers and community health systems in LMICs
Dr Afreenish Amir
specialises in AMR surveillance, advocacy, stewardship and laboratory systems. Her work focuses on pathogen genomic and fungal surveillance, cholera control, antimicrobial treatment guidelines, GHSA AMR action package, LQMS, biorisk management. She is member of WHO BPPL, research agenda, GIBACHT fellow, Harvard Kennedy school alumna, and visiting faculty RMU and HSA Pakistan.
Dr Claire Gordon
Clinical microbiologist and infectious diseases physician. Deputy head of the UKHSA Rare and Imported Pathogens Laboratory (RIPL), also works in the NHS. Long standing research interest in AMR, particularly the use of laboratory diagnostics to improve frontline antimicrobial use both in the UK and in low- and middle-income settings.